JAMA Oncology (@jamaonc) 's Twitter Profile
JAMA Oncology

@jamaonc

JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

ID: 2811548749

linkhttp://ja.ma/tjamaoncology calendar_today15-09-2014 15:33:04

18,18K Tweet

47,47K Takipçi

513 Takip Edilen

JAMA Oncology (@jamaonc) 's Twitter Profile Photo
JAMA Oncology
@jamaonc

a month ago

The management of brain metastases in EGFR-variant and ALK-positive NSCLC patients remains uncertain, with evidence suggesting that upfront stereotactic radiosurgery (SRS) offers better local control and delays CNS progression. ja.ma/4k5ldos @Pike_lab

The management of brain metastases in EGFR-variant and ALK-positive NSCLC patients remains uncertain, with evidence suggesting that upfront stereotactic radiosurgery (SRS) offers better local control and delays CNS progression. ja.ma/4k5ldos @Pike_lab